U.S. markets close in 2 hours 56 minutes
  • S&P 500

    3,946.42
    -2.30 (-0.06%)
     
  • Dow 30

    32,097.02
    -8.23 (-0.03%)
     
  • Nasdaq

    11,736.99
    -50.41 (-0.43%)
     
  • Russell 2000

    1,722.17
    +1.88 (+0.11%)
     
  • Crude Oil

    68.96
    -1.00 (-1.43%)
     
  • Gold

    1,989.40
    -6.50 (-0.33%)
     
  • Silver

    23.36
    +0.11 (+0.47%)
     
  • EUR/USD

    1.0761
    -0.0076 (-0.70%)
     
  • 10-Yr Bond

    3.3780
    -0.0280 (-0.82%)
     
  • GBP/USD

    1.2220
    -0.0069 (-0.56%)
     
  • USD/JPY

    130.7430
    -0.0460 (-0.04%)
     
  • Bitcoin USD

    27,873.85
    -650.49 (-2.28%)
     
  • CMC Crypto 200

    606.98
    -11.41 (-1.84%)
     
  • FTSE 100

    7,405.45
    -94.15 (-1.26%)
     
  • Nikkei 225

    27,385.25
    -34.36 (-0.13%)
     

The Petri Dish: Morphic, J&J part ways; FDA committee to review another Biogen drug

The Petri Dish: Morphic, J&J part ways; FDA committee to review another Biogen drug

Waltham biotech Morphic Holding Inc. is no longer working with Johnson & Johnson Inc. after the pharma giant elected to terminate a nearly four-year-old collaboration agreement.